Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Varga

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
ACS Omega|December 1, 2025
Detailed Physicochemical Analysis of Hyaluronic Acid and Transferrin Self-Assembly To Produce Drug Carrier ColloidsLászló Seres, Norbert Varga, Bianka Torma, et al.
International Journal of Molecular Sciences|September 28, 2021
The pH-Dependent Controlled Release of Encapsulated Vitamin B<sub>1</sub> from Liposomal NanocarrierÁdám Juhász, Ditta Ungor, Egon Z Várkonyi, et al.
Nanomaterials (Basel, Switzerland)|December 24, 2021
Detailed Calorimetric Analysis of Mixed Micelle Formation from Aqueous Binary Surfactants for Design of Nanoscale Drug CarriersÁdám Juhász, László Seres, Norbert Varga, et al.
Carbohydrate Polymers|May 29, 2018
Cross-linked and hydrophobized hyaluronic acid-based controlled drug release systemsEdit Csapó, Hajnalka Szokolai, Ádám Juhász, et al.
International Journal of Molecular Sciences|September 28, 2023
Lipid-Based Nanocarriers for Delivery of Neuroprotective Kynurenic Acid: Preparation, Characterization, and BBB TransportÁdám Juhász, Ditta Ungor, Norbert Varga, et al.
Journal of Combinatorial Chemistry|January 10, 2006
Continuous-flow high pressure hydrogenation reactor for optimization and high-throughput synthesisRichard V Jones, Lajos Godorhazy, Norbert Varga, et al.
Stem Cell Research|October 30, 2016
Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutationEszter Varga, Csilla Nemes, István Bock, et al.
Stem Cell Research|October 30, 2016
Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 7-year-old male with pathogenic IDS mutationEszter Varga, Csilla Nemes, István Bock, et al.
Stem Cell Research|October 30, 2016
Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutationEszter Varga, Csilla Nemes, István Bock, et al.
Chemmedchem|February 3, 2015
Drug discovery summit: 11(th) Swiss Course on Medicinal ChemistryPriska Frei, Giulio Navarra, Christoph P Sager, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
ACS Omega|December 1, 2025
Detailed Physicochemical Analysis of Hyaluronic Acid and Transferrin Self-Assembly To Produce Drug Carrier ColloidsLászló Seres, Norbert Varga, Bianka Torma, et al.
International Journal of Molecular Sciences|September 28, 2021
The pH-Dependent Controlled Release of Encapsulated Vitamin B<sub>1</sub> from Liposomal NanocarrierÁdám Juhász, Ditta Ungor, Egon Z Várkonyi, et al.
Nanomaterials (Basel, Switzerland)|December 24, 2021
Detailed Calorimetric Analysis of Mixed Micelle Formation from Aqueous Binary Surfactants for Design of Nanoscale Drug CarriersÁdám Juhász, László Seres, Norbert Varga, et al.
Carbohydrate Polymers|May 29, 2018
Cross-linked and hydrophobized hyaluronic acid-based controlled drug release systemsEdit Csapó, Hajnalka Szokolai, Ádám Juhász, et al.
International Journal of Molecular Sciences|September 28, 2023
Lipid-Based Nanocarriers for Delivery of Neuroprotective Kynurenic Acid: Preparation, Characterization, and BBB TransportÁdám Juhász, Ditta Ungor, Norbert Varga, et al.
Journal of Combinatorial Chemistry|January 10, 2006
Continuous-flow high pressure hydrogenation reactor for optimization and high-throughput synthesisRichard V Jones, Lajos Godorhazy, Norbert Varga, et al.
Stem Cell Research|October 30, 2016
Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutationEszter Varga, Csilla Nemes, István Bock, et al.
Stem Cell Research|October 30, 2016
Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 7-year-old male with pathogenic IDS mutationEszter Varga, Csilla Nemes, István Bock, et al.
Stem Cell Research|October 30, 2016
Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutationEszter Varga, Csilla Nemes, István Bock, et al.
Chemmedchem|February 3, 2015
Drug discovery summit: 11(th) Swiss Course on Medicinal ChemistryPriska Frei, Giulio Navarra, Christoph P Sager, et al.
Pageof 5